Joseph G. Pressey · Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib
Follow
Article1 min read·Published Sep 2021Older

Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Sep 2021 · 1 min read

In brief

In brief

Case report of a metastatic spindle cell tumor with myofibroblastic features harboring a novel ARHGAP23-FER gene fusion that demonstrated sustained metabolic response to the targeted kinase inhibitor lorlatinib.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Cancer · 2021

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.